Diagnosis of growth hormone deficiency after pituitary surgery: The combined acipimox/GH-releasing hormone test

Clinical Endocrinology

Volumn 58, Issue 2, 2003, Pages 156-162

  Van Dam, P Sytze ^a   Dieguez, Carlos ^b   Cordido, Fernando ^c   De Vries, Wouter R ^a   Veldhuyzen, Bernard F E ^d   Van Thiel, E ^d   Casanueva, Felipe F ^b   Koppeschaar, Hans P F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d AMPHIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX; ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; NEDIOS; NEUTRAL INSULIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DOSE TIME EFFECT RELATION; FATTY ACID METABOLISM; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; INSULIN TOLERANCE TEST; INTERMETHOD COMPARISON; MALE; MENINGIOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROLACTINOMA; STANDARD; TIME SERIES ANALYSIS; TRANSSPHENOIDAL SURGERY;

ADENOMA; ADOLESCENT; ADULT; AGED; AREA UNDER CURVE; ARGININE; FATTY ACIDS, NONESTERIFIED; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; INSULIN; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; PYRAZINES; STIMULATION, CHEMICAL;

EID: 0037318896     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01684.x     Document Type: Article

References (17)

1. Andreotti, A.C., Lanzi, R., Manzoni, M.F., Caumo, A., Moreschi, A. & Pontiroli, A.E. (1994) Acute pharmacologic blockade of lipolysis normalizes nocturnal growth hormone levels and pulsatility in obese subjects. Metabolism, 43, 1207-1213.
2. Anonymous (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 379-381.
3. Biller, B.M.K., Samuels, M.H., Zagar, A., Cook, D.M., Arafah, B.M., Bonert, V., Stavrou, S., Kleinberg, D.L., Chipman, J.J. & Hartman, M.L. (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism, 87, 2067-2079.
4. Casanueva, F.F., Villanueva, L., Dieguez, C., Diaz, Y., Cabranes, J.A., Szoke, B., Scanlon, M.F., Schally, A.V. & Fernandez Cruz, A. (1987) Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. Journal of Clinical Endocrinology and Metabolism, 65, 634-642.
5. Cordido, F., Peino, R., Penalva, A., Alvarez, C.V., Casanueva, F.F. & Dieguez, C. (1996) Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. Journal of Clinical Endocrinology and Metabolism, 81, 914-918.
6. Cordido, F., Fernandez, T., Martinez, T., Penalva, A., Peino, R., Casanueva, F.F. & Dieguez, C. (1998) Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 83, 4350-4354.
7. Ghigo, E., Aimaretti, G., Gianotti, L., Bellone, J., Arvat, E. & Camanni, F. (1996) New approach to the diagnosis of growth hormone deficiency in adults. European Journal of Endocrinology, 134, 352-356.
8. Ho, K.K. (2000) Diagnosis of adult GH deficiency. Lancet, 356, 1125-1126.
9. Hoffman, D.M., O'Sullivan, A.J., Baxter, R.C. & Ho, K.K. (1994) Diagnosis of growth-hormone deficiency in adults. Lancet, 343, 1064-1068.
10. Lee, E.J., Nam, S.Y., Kim, K.R., Lee, H.C., Cho, J.H., Nam, M.S., Song, Y.D., Lim, S.K. & Huh, K.B. (1995) Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridosfigmine by lowering serum free fatty acid in normal and obese subjects. Journal of Clinical Endocrinology and Metabolism, 80, 2495-2498.
11. Maccario, M., Procopio, M., Grottoli, S., Oleandri, S.E., Boffano, G.M., Taliano, M., Camanni, F. & Ghigo, E. (1996) Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. Metabolism, 45, 342-346.
12. Nam, S.Y., Lee, Kim, K.R., Lee, H.C., Nam, M.S., Cho, J.H. & Huh, K.B. (1996) Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity. Metabolism, 45, 594-597.
13. Perez, F.R., Casabiell, X., Camina, J.P., Zugaza, J.L. & Casanueva, F.F. (1997) cis-unsaturated free fatty acids block growth hormone and prolactin secretion in thyrotropin-releasing hormone-stimulated GH3 cells by perturbing the function of plasma membrane integral proteins. Endocrinology, 138, 264-272.
14. Piatti, P.M., Monti, L.D., Pacchioni, M., Pontiroli, A.E. & Pozza, G. (1991) Forearm insulin- and non-insulin-mediated glucose uptake and muscle metabolism in man: role of free fatty acids and blood glucose levels. Metabolism, 40, 926-933.
15. Pontiroli, A.E., Manzoni, M.F., Malighetti, M.E. & Lanzi, R. (1996) Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids. Journal of Clinical Endocrinology and Metabolism, 81, 3998-4001.
16. Popovic, V., Leal, A., Micic, D., Koppesehaar, H.P.F., Torres, E., Paramo, C., Obradovic, S., Dieguez, C. & Casanueva, F.F. (2000) GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults. Lancet, 356, 1137-1142.
17. Van Dam, P.S., Smid, H.E.C., de Vries, W.R., Niesink, M., Bolscher, E., Waasdorp, E.J., Dieguez, C., Casanueva, F.F. & Koppeschaar, H.P.F. (2000) Reduction of free fatty acids by acipimox enhances the growth hormone (GH) responses to GH-releasing pepfide 2 in elderly men. Journal of Clinical Endocrinology and Metabolism, 85, 4706-4711.